The FDA approved Aurobindo Pharma's version of Razadyne, Ortho-McNeil-Janssen Pharmaceuticals' oral treatment for Alzheimer's disease. The generic, galantamine, will be marketed in doses of 4, 8 and 12 milligrams.
Published in Brief:
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||